ALLMedicine™ Biliary Disease Center

Mar 8th, 2023 - A comprehensive evaluation of the risks and 1-year burdens of gastrointestinal disorders in the post-acute phase of COVID-19 is needed but is not yet available. Here we use the US Department of Veterans Affairs national health care databases to bu...

Mar 4th, 2023 - Adult Primary Sclerosing Cholangitis (PSC) subjects have worse outcomes compared to pediatric PSC subjects. The reasons for this observation are not completely understood. In this single-center, retrospective (2005-17) study we compared clinical i...

Mar 1st, 2023 - Introduction Cholelithiasis occurs in 10-20% of the general population (1). Up to 18% of these subjects will present symptoms and, of these, 1.5% will present an episode of pancreatitis, cholecystitis or acute cholangitis (2). In this way, the pat...

Feb 24th, 2023 - This review focuses on recent developments of histopathology in the most common biliary disorders affecting adults. The reader is referred to other sources for the specialized topics on paediatric populations and post liver transplantation. Fibros...

Jan 20th, 2023 - To study the utility of 2D shear wave elastography (SWE) and ascertain cut-off values of shear wave elasticity (SWe) to differentiate benign and malignant thickening of the gallbladder wall. This study was a prospective study of patients with symp...

Aug 1st, 2021 - Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chr...

May 6th, 2019 - Although right upper quadrant pain is a very common clinical presentation, it can be nonspecific. However, acute cholecystitis is very often the diagnosis of exclusion. This review focuses on the recommended imaging evaluation in the most commonly...

Jan 12th, 2013 - In 2007, the Tokyo Guidelines for the management of acute cholangitis and cholecystitis (TG07) were first published in the Journal of Hepato-Biliary-Pancreatic Surgery. The fundamental policy of TG07 was to achieve the objectives of TG07 through t...

Jul 25th, 2012 - The Tokyo Guidelines for the management of acute cholangitis and cholecystitis were published in 2007 (TG07) and have been widely cited in the world literature. Because of new information that has been published since 2007, we organized the Tokyo ...

Mar 1st, 2023 - Introduction Cholelithiasis occurs in 10-20% of the general population (1). Up to 18% of these subjects will present symptoms and, of these, 1.5% will present an episode of pancreatitis, cholecystitis or acute cholangitis (2). In this way, the pat...

Nov 22nd, 2022 - Pediatric primary sclerosing cholangitis (PSC) is a rare autoimmune biliary fibrosing disease that leads to significant morbidity, the need for liver transplantation in ~50% of patients, and an increased risk for biliary and colorectal cancers in ...

Oct 21st, 2022 - The current goal in the treatment of Alcoholic Liver Disease (ALD) is to manage ALD-associated complications as there are no disease-specific therapies. Identifying disease-specific therapies to slow ALD progression is critical to improving the ou...

Aug 16th, 2022 - Acute cholecystitis is considered one of the most common acute surgical problems. It includes typical symptoms of pain in right hypochondrium, fever, increased leucocytes count and abdominal US used to confirm this clinical diagnosis. Laparoscopic...

Jul 21st, 2022 - The sample of biliary aspirate will be assessed as follows. Its macroscopic appearance will be analyzed: yellow, black, or purulent. Biliary culture will be performed; if bacterial growth is observed, its identification will be carried out by mean...

Jul 31st, 2022 - Key clinical point: Dipeptidyl peptidase-4 (DPP4) inhibitors significantly increased the risk for the composite of gallbladder or biliary diseases and cholecystitis but not for cholelithiasis and biliary diseases in patients with type 2 diabetes (.

Mar 28th, 2022 - A certain class of antidiabetic agent was linked with gallbladder and biliary diseases, researchers reported. According to a systematic review and meta-analysis of 76 randomized clinical trials, use of glucagon-like peptide-1 receptor agonists (GL...

Mar 28th, 2022 - Treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist was associated with a 37% increase in the relative risk of gallbladder or biliary disease compared with controls — especially when used at high doses, for a longer time, and for wei...

Feb 16th, 2022 - Gallbladder duplication is a congenital abnormality of the hepatobiliary system and often is not considered in the evaluation of a patient with right upper quadrant pain. Accuracy of the most commonly used imaging study to assess for biliary disea.

Oct 11th, 2018 - PHILADELPHIA — The shift from open bariatric surgery to laparoscopic surgery over the past decade has led to an increase in biliary disease, results from a retrospective study suggest. "Obviously, we don't suggest switching back to open bariatric ...